Emerj · AI in Business
Where AI Should Actually Earn Its Keep in Biopharma
A conversation with Mukhtar Ahmed of Greenstone Biosciences about AI’s role in biopharma and the decisions that turn scientific opportunity into development priorities.
Media & conversations
Putting the ideas
in conversation.
Interviews and discussions on science, AI, portfolio strategy, and the future of drug development.
COG
Leadership Insights into Pipeline Strategy
A conversation with Mukhtar Ahmed on leadership and pipeline strategy.
Editorial & speaking inquiries
For interviews, invited talks, and conversations on drug development, AI, and strategic judgment.
mukhtar@mukhtarahmedphd.com